{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:53:59Z","timestamp":1771548839340,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.urology.2011.02.065","type":"journal-article","created":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T10:42:31Z","timestamp":1309257751000},"page":"250-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Long-term Fluoroquinolone Use Before the Prostate Biopsy May Increase the Risk of Sepsis Caused by Resistant Microorganisms"],"prefix":"10.1016","volume":"78","author":[{"given":"B\u00fclent","family":"Akduman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Akduman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcsn\u00fc","family":"Tokg\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fclent","family":"Erol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u011frul","family":"T\u00fcrker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferruh","family":"Ayo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necmettin","family":"Ayd\u0131n Mungan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2011.02.065_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00182468","article-title":"Determinants of complications after multiple transrectal core biopsies of the prostate","volume":"6","author":"Norberg","year":"1996","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urology.2011.02.065_bib2","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/01.ju.0000061280.23447.29","article-title":"Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy","volume":"169","author":"Tal","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.02.065_bib3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0022-5347(05)65186-5","article-title":"Treatment of chronic prostatitis lowers serum prostate specific antigen","volume":"167","author":"Bozeman","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.02.065_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1464-410x.2000.00576.x","article-title":"Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study","volume":"85","author":"Aron","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2011.02.065_bib5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.juro.2007.10.071","article-title":"The incidence of fluoroquinolone resistant infections after prostate biopsy\u2014are fluoroquinolones still effective prophylaxis?","volume":"179","author":"Feliciano","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.02.065_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1442-2042.2007.01975.x","article-title":"Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature","volume":"15","author":"Miura","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2011.02.065_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jac\/49.1.55","article-title":"Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis","volume":"49","author":"Horcajada","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2011.02.065_bib8","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"SCCM\/ESICM\/ACCP\/ATS\/SIS","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.urology.2011.02.065_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-5347(01)67064-2","article-title":"Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels","volume":"154","author":"Nadler","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.02.065_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","article-title":"Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value","volume":"157","author":"Irani","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.02.065_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.pcan.4500885","article-title":"Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng\/mL","volume":"9","author":"Kaygisiz","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2011.02.065_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1159\/000052500","article-title":"Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng\/ml and nonsuspicious results of digital rectal examination","volume":"39","author":"Karazanashvili","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2011.02.065_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000277596","article-title":"Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: a prospective randomized controlled trial","volume":"84","author":"Ugurlu","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2011.02.065_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng\/ml or lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2011.02.065_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urolonc.2008.04.002","article-title":"Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)","volume":"27","author":"Loeb","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2011.02.065_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2008.12.067","article-title":"Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy","volume":"74","author":"Ozden","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.02.065_bib17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/502312","article-title":"Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon","volume":"25","author":"Otrock","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.urology.2011.02.065_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.urology.2009.07.1222","article-title":"Bacterial sepsis after prostate biopsy\u2014a new perspective","volume":"74","author":"Lange","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.02.065_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/AAC.40.2.503","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis","volume":"40","author":"Carratala","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2011.02.065_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/AAC.38.2.340","article-title":"Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis","volume":"38","author":"Dupeyron","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2011.02.065_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.510250306","article-title":"Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin","volume":"25","author":"Novella","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.urology.2011.02.065_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/44.1.117","article-title":"Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis","volume":"44","author":"Perea","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2011.02.065_bib23","first-page":"3653","article-title":"Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis","volume":"14","author":"Cannon","year":"2007","journal-title":"Can J Urol"},{"key":"10.1016\/j.urology.2011.02.065_bib24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archinte.165.12.1375","article-title":"Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection","volume":"165","author":"Hyle","year":"2005","journal-title":"Arch Intern Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511003591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511003591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:55:18Z","timestamp":1758765318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429511003591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0090429511003591"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2011.02.065","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Fluoroquinolone Use Before the Prostate Biopsy May Increase the Risk of Sepsis Caused by Resistant Microorganisms","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2011.02.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}